Merck Mobius® CellReady Single-Use Bioreactor

Overview

The Merck Mobius® CellReady Single-Use Bioreactor is an engineered, scalable platform designed for mammalian and microbial cell culture applications across process development, clinical manufacturing, and commercial production. Based on the proven hydrodynamic principles of stirred-tank bioreactors (STBRs), the Mobius® CellReady system replicates key mixing, mass transfer, and shear characteristics of traditional stainless-steel (SS) systems—enabling seamless technology transfer and process validation continuity. Its disposable bag-in-cage architecture eliminates cleaning-in-place (CIP) and sterilization-in-place (SIP) requirements, significantly reducing turnaround time between batches and minimizing cross-contamination risk. The system operates under controlled conditions—including pH, dissolved oxygen (DO), temperature, agitation, and headspace gas composition—making it suitable for adherent and suspension cultures, including CHO, HEK293, and hybridoma cells.

Key Features

• Modular, rigid base station design with integrated motor drive, temperature control jacket interface, and sensor porting—ensuring mechanical stability, repeatable installation, and long-term operational reliability.
• CellReady™ bag assemblies pre-sterilized via gamma irradiation (25–40 kGy), validated for extractables and leachables per USP and , and compliant with ISO 10993-5/10 for cytotoxicity and sensitization testing.
• SensorReady™ technology enables plug-and-play integration of inline and at-line sensors—including optical DO/pH probes, capacitance-based viable cell density (VCD) sensors, and pressure transducers—without custom bag fabrication or welding.
• Flexible automation compatibility: supports native integration with Finesse SmartDose™ and SmartTune™ controllers, or third-party SCADA/DCS platforms via Modbus TCP or OPC UA protocols.
• Scalable footprint: available in 3 L (benchtop), 50 L (pilot-scale), and 200 L (clinical/commercial) working volumes—all sharing identical impeller geometry, sparging configuration, and control logic to ensure linear scale-up.

Sample Compatibility & Compliance

The Mobius® CellReady bioreactor accommodates a broad range of suspension and microcarrier-based adherent cell lines, including but not limited to CHO-K1, CHO-S, PER.C6®, CAP-T®, and Sf9 insect cells. All contact surfaces comply with USP Class VI plastic standards and meet FDA-recommended guidelines for single-use systems in biopharmaceutical manufacturing. The platform supports compliance with ICH Q5A(R2), Q5D, and Q5E for cell line characterization and process consistency. Full documentation packages—including Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Risk Assessments (FMEA)—are provided to support GMP audits and regulatory submissions (e.g., IND, BLA, MAA).

Software & Data Management

Mobius® CellReady systems integrate with Merck’s Bio4C™ Process Analytics software suite, enabling real-time data acquisition, multivariate statistical process monitoring (MSPC), and electronic batch record (EBR) generation. The software complies with 21 CFR Part 11 requirements through role-based access control, full audit trail logging, electronic signatures, and data integrity safeguards. Raw sensor data are timestamped and stored in secure, encrypted SQL databases with configurable backup intervals and retention policies aligned with ALCOA+ principles. Optional cloud-enabled remote monitoring (via Bio4C Connect) allows authorized users to review trends, receive alarm notifications, and initiate predefined SOP-driven actions from offsite locations.

Applications

• Upstream process development: rapid screening of media formulations, feeding strategies, and operating parameters (e.g., agitation speed, DO setpoints, pH profiles).
• Clinical-grade material production: GMP-compliant manufacture of monoclonal antibodies (mAbs), bispecifics, viral vectors (AAV, lentivirus), and recombinant proteins under Annex 1-aligned environmental controls.
• Process characterization and validation: execution of design-of-experiments (DoE) studies to define proven acceptable ranges (PARs) and edge-of-failure conditions.
• Technology transfer: bridging legacy stainless-steel processes to single-use infrastructure while maintaining critical quality attributes (CQAs) and process performance qualification (PPQ) outcomes.
• Training and education: standardized platform for teaching bioprocess engineering fundamentals in academic and internal training environments.

FAQ

What is the maximum recommended operating pressure for Mobius® CellReady bags?
Standard CellReady bags are rated for up to 0.5 bar(g) overpressure; high-pressure variants (e.g., for intensified perfusion modes) support up to 1.0 bar(g) with validated vent filter configurations.
Can Mobius® CellReady be used for perfusion culture?
Yes—the 50 L and 200 L systems support integrated tangential flow filtration (TFF) and alternating tangential flow (ATF) skids via standardized fluidic interfaces and pump synchronization protocols.
Is SensorReady™ compatible with third-party sensors?
SensorReady™ provides mechanical and electrical standardization (e.g., ISM-compatible connectors, 4–20 mA/RS-485 interfaces); however, only Merck-qualified sensors undergo full extractables, calibration traceability, and long-term stability validation.
How is bag integrity verified prior to inoculation?
Pre-use integrity testing (PUIT) is performed using pressure hold or decay methods per ASTM F2096, with pass/fail criteria defined by bag volume, duration, and allowable pressure loss thresholds documented in the Certificate of Conformance.
Does Merck provide process-specific support for regulatory filings?
Yes—Merck offers Technical Support Services including process characterization reports, comparability assessments, and regulatory consultation aligned with EMA CHMP/BWP and FDA CBER expectations for single-use system adoption.